Keywords: cv, thera, narrows, loss, ranexa, sales, drugmaker

CV Thera narrows loss on Ranexa sales

Article | 09 March 2009

Print This

US drugmaker CV Therapeutics narrowed its loss by 46% during 2008, compared to the year before, on higher collaboration, royalty and product ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in